Implementation and Evaluation of a Nurse-Led Decision-Coaching Program for Healthy Breast Cancer Susceptibility Gene (BRCA1/2) Mutation Carriers: A Study Protocol for the Randomized Controlled EDCP-BRCA Study
Affiliations
- PMID: 32513307
- PMCID: PMC7278068
- DOI: 10.1186/s13063-020-04431-x
Abstract
Background: Female BRCA mutation carriers have an increased lifetime risk for breast and ovarian cancer compared to the general population. Women who carry this mutation have several options to deal with their cancer risk, such as risk-reducing surgeries or intensified breast cancer screening. Previous research has shown that preferences in this scenario are highly dependent on affected women's personalities and value systems. To support these women in the decision-making process, a structured decision support consisting of decision coaching combined with a decision aid might be helpful.
Methods/design: A randomized controlled trial will be conducted in order to compare usual care with structured decision support alongside usual care. The decision support program entails nurse-led decision coaching as well as an evidence-based patient decision aid. Nurses are qualified by a 4-day training program in informed decision-making and decision coaching. Six centers for Familial Breast and Ovarian Cancer in Germany will be included in the study, with a planned sample size of 398 women. The primary outcome is the congruence between the preferred and the actual played role in the decision-making process as measured by the Control Preferences Scale. It is hypothesized that the structured decision support will enable women to play the preferred role in the decision-making process. Secondary outcomes include the knowledge and attitudes about preventive options, decisional conflict, depression and anxiety, coping self-efficacy, impact of event, and self-concept. A process evaluation will accompany the study.
Discussion: The EDCP-BRCA study is the first study to implement and evaluate decision coaching combined with a decision aid for healthy BRCA mutation carriers worldwide. TRIAL REGISTRATION {2A}: DRKS-ID: DRKS00015527. Registered 30 October 2019.
Keywords: BRCA1 and BRCA2; Decision aid; Decision coaching; Decision making; Familial breast cancer; Familial ovarian cancer; Patient-centered care; Shared decision-making.
Conflict of interest statement
AI, none to declare
MT, none to declare
BBH, none to declare
AS, none to declare
FV, Funding by German Research Foundation (DFG) and German Cancer Aid for research regarding communication skills trainings. Further funding by German Innovationsfonds and BMBF.
RW, none to declare
KR, none to declare
RS, none to declare
SST, none to declare
No hay comentarios:
Publicar un comentario